patent, disease & medicine
How to Successfully Collaborate with Industry
How to Successfully Collaborate with Industry
Ashley P. Taylor | Mar 1, 2018
In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.
2017 in Quotes
2017 in Quotes
Catherine Offord | Dec 28, 2017
Gender discrimination, Brexit, and climate change are among the issues that have received considerable attention from the scientific community this year.
2017’s Science News in Review
2017’s Science News in Review
Kerry Grens | Dec 15, 2017
Hurricanes, protests, and lifesaving genetic engineering: our picks for the biggest stories of the year
Flux and Uncertainty in the CRISPR Patent Landscape
Flux and Uncertainty in the CRISPR Patent Landscape
Aggie Mika | Oct 1, 2017
The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.
Zika Linked to More Neurological Problems in Adults
Zika Linked to More Neurological Problems in Adults
Kerry Grens | Aug 14, 2017
A review of several dozen hospitalized patients in Brazil finds neurological conditions, including inflammation of the brain and spinal cord, in addition to Guillain-Barre syndrome.
Nature Index Identifies Top Contributors to Innovation
Nature Index Identifies Top Contributors to Innovation
Catherine Offord | Aug 9, 2017
New rankings highlight institutions that have produced large numbers of articles cited in others' patents.
UC Berkeley: Patent Office “Ignored Key Evidence”
UC Berkeley: Patent Office “Ignored Key Evidence”
Jef Akst | Jul 26, 2017
The University of California files a brief in its appeal challenging the ruling that the Broad Institute’s group would retain its CRISPR genome-editing patent.
The Invention Return on NIH Investments
The Invention Return on NIH Investments
Kerry Grens | Apr 2, 2017
Around 8 percent of grants funded by the National Institutes of Health resulted in patents.
UC Berkeley Receives CRISPR Patent in Europe
UC Berkeley Receives CRISPR Patent in Europe
Jef Akst | Mar 24, 2017
The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.
Broad Wins CRISPR Patent Interference Case
Broad Wins CRISPR Patent Interference Case
Jef Akst | Feb 15, 2017
The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.